Protective effects of L- and D-carnosine on α-crystallin amyloid fibril formation: Implications for cataract disease

Biochemistry

Volumn 48, Issue 27, 2009, Pages 6522-6531

  Attanasio, Francesco ^a   Cataldo, Sebastiano ^b   Fisichella, Salvatore ^c   Nicoletti, Silvia ^c   Nicoletti, Vincenzo Giuseppe ^c,d   Pignataro, Bruno ^b   Savarino, Anna ^c   Rizzarelli, Enrico ^c  

^a CNR   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d National Institute of Biosystems and Biostructures   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID FIBRIL; AMYLOID FIBRIL FORMATION; CARNOSINE; CHAPERONE ACTIVITY; CRYSTALLIN; DENATURING CONDITIONS; DIPEPTIDE; FIBRILLAR STRUCTURES; HEAT STRESS; IN-VITRO; INHIBITORY EFFECT; LENS PROTEINS; LENS TRANSPARENCY; POLYPEPTIDE CHAIN; PROTECTIVE EFFECTS; SCANNING FORCE MICROSCOPY; SELF-ASSEMBLE; SENILE CATARACT; STRUCTURAL ELEMENTS; THIOFLAVIN T;

AMINES; LENSES; OPTICAL INSTRUMENTS; POLYPEPTIDES; RESTORATION; SCANNING TUNNELING MICROSCOPY; SUGAR (SUCROSE);

GLYCOPROTEINS;

ALPHA CRYSTALLIN; BETA CRYSTALLIN; CARNOSINE; THIOFLAVINE;

ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; ENANTIOMER; FEMALE; LENS; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN DENATURATION; RAT; SCANNING FORCE MICROSCOPY; TURBIDIMETRY;

ALPHA-CRYSTALLINS; AMYLOID; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CARNOSINE; CATARACT; CATTLE; CIRCULAR DICHROISM; FEMALE; MICROSCOPY, ATOMIC FORCE; MOLECULAR CHAPERONES; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

BOVINAE; RATTUS;

EID: 67650045638     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900343n     Document Type: Article

References (58)

1. Bloemendal, H. (1981) in Molecular and Cellular Biology of the Eye Lens , Wiley, New York.
2. Horwitz, J. (1992) α-Crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. U.S.A. 89, 10449-10453.
3. Horwitz, J. (2003) α-Crystallin. Exp. Eye Res. 76, 145-153.
4. Harding, J. J. (2002) Viewing molecular mechanisms of ageing through a lens. Ageing Res. Rev. 1, 465-479.
5. Derham, B. K., and Harding, J. J. (2002) Effects of modifications of α-crystallin on its chaperone and other properties. Biochem. J. 364, 711-717.
6. Spector, A., Li, L. K., Augusteyn, R. C., Schneider, A., and Freund, T. (1971) α-Crystallin. The isolation and characterization of distinct macromolecular fractions. Biochem. J. 124, 337-343.
7. Liang, J. J.-N., and Akhtar, N. J. (2000) Human lens high-molecular- weight α-crystallin aggregates. Biochem. Biophys. Res. Commun. 275, 354-359.
8. Fujii, N., Awakura, M., Takemoto, L., Inomata, M., Tarata, T., Fujii, N., and Saito, T. (2003) Characterization of αA-crystallin from high molecular weight aggregates in the normal human lens. Mol. Vision 9, 315-322.
9. Sunde, M., and Blake, C. C. (1998) From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 31, 1-39.
10. Van Boekel, M. A., Hoogakker, S. E., Harding, J. J., and De Jong, W. W. (1996) The infuence of some post-translational modifications on the chaperone-like activity of α-crystallin. Ophthalmic Res. 28, 32-38.
11. Pande, A., Pande, J., Asherie, N., Lomakin, A., Ogun, O., King, J. A., Lubsen, N. H., Walton, D., and Benedek, G. B. (2000) Crystal cataracts: Human genetic cataracts caused by protein crystallization. Proc. Natl. Acad. Sci. U.S.A. 97, 1993-1998.
12. Harding, J. J. (1998) Cataract, Alzheimer's disease, and other conformational diseases. Curr. Opin. Ophthalmol. 9, 10-13.
13. Meehan, S., Berry, Y., Luisi, B., Dobson, C. M., Carver, J. A., and MacPhee, C. E. (2004) Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J. Biol. Chem. 279, 3413-3419.
14. Meehan, S., Knowles, T. P. J., Baldwin, A. J., Smith, J. F., Squires, A. M., Clements, P., Treweek, T. M., Ecroyd, H., Tartaglia, G. G., Vendruscolo, M., MacPhee, C. E., Dobson, C. M., and Carver, J. A. (2007) Characterisation of amyloid fibril formation by small heatshock chaperone proteins human αA-, αB- and R120G αB-crystallin. J. Mol. Biol. 372, 470-484.
15. Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., and Nukina, N. (2004) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 10, 148-154.
16. Arora, A., Ha, C., and Park, C. B. (2004) Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett. 564, 121-125.
17. Akashi, K., Miyake, C., and Yokota, A. (2001) Citrulline, a novel compatible solute in drought-tolerant wild watermelon leaves, is an efficient hydroxyl radical scavenger. FEBS Lett. 508, 438-442.
18. Tanaka, M., Machida, Y., and Nukina, N. J. (2005) A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules. Mol. Med. 83, 343-352.
19. Yan, H., and Harding, J. J. (2006) Carnosine inhibits modifications and decreased molecular chaperone activity of lens α-crystallin induced by ribose and fructose 6-phosphate. Mol. Vision 12, 205-214.
20. Attanasio, F., Cascio, C., Fisichella, S., Nicoletti, V. G., Pignataro, B., Savarino, A., and Rizzarelli, E. (2007) Trehalose effects on α-crystallin aggregates. Biochem. Biophys. Res. Commun. 354, 899-905.
21. McFarland, G. A., and Holliday, R. (1994) Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp. Cell Res. 212, 167-175.
22. Gariballa, S. E., and Sinclair, A. J. (2000) Carnosine: Physiological properties and therapeutic potential. Age Ageing 29, 207-210.
23. Hipkiss, A. R., Michaelis, J., and Syrris, P. (1995) Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett. 371, 81-85.
24. Brownson, C., and Hipkiss, A. R. (2000) Carnosine reacts with a glycated protein. Free Radical Biol. Med. 28, 1564-1570.
25. Seidler, N. W., Yeargans, G. S., and Morgan, T. G. (2004) Carnosine disaggregates glycated α-crystallin: An in vitro study. Arch. Biochem. Biophys. 427, 110-115.
26. Kang, J. H., Kim, K. S., Choi, S. Y., Kwon, H. Y., Won, M. H., and Kang, T. C. (2002) Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu,Zn-superoxide dismutase modification. Biochim. Biophys. Acta 1570, 89-96.
27. Yan, H., and Harding, J. J. (2005) Carnosine protects against the inactivation of esterase induced by glycation and steroid. Biochim. Biophys. Acta 1741, 120-126.
28. Yan, H., and Harding, J. J. (2006) Protective effects of carnosine against the inactivation of ezymes induced by glycation and steroid: Relevance to cataract. Am. J. Ophthalmol. 139 (Suppl.), S55.
29. Hipkiss, A. R., Presto, J. E., Himswoth, D. T., Worthington, V. C., and Abbot, N. J. (1997) Protective effects of carnosine against malondialdehyde- induced toxicity towards cultured rat brain endothelial cells. Neurosci. Lett. 238, 135-138.
30. Babizhayev, M. A., Guiotto, A., and Kasus-Jacobi, A. (2009) N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications. J. Drug Targeting 17, 36-63.
31. Babizhayev, M. A., Deyev, A. I., Yermakova, V. N., Remenshchikov, V. V., and Bours, J. (2006) Revival of lens transparency with N-acetylcarnosine. Curr. Drug Ther. 1, 91-116.
32. Boldyrev, A., Bulygina, E., Leinsoo, T., Tsubone, I. P. S., and Abe, H. (2000) Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol. 127, 443-446.
33. Aldini, G., Canevotti, R., and Negrisoli, G. Compositions containing D-carnosine. Patent WO 2005/120543.
34. Pignataro, B., Chi, L. F., Gao, S., Anczykowski, B., Niemeyer, C. M., Adler, M., Blohm, D., and Fuchs, H. (2002) Dynamic scanning force microscopy study of self-assembled DNA-protein oligomers. Appl. Phys. A: Mater. Sci. Process. 74, 447-452.
35. Pignataro, B., Sardone, L., and Marletta, G. (2003) Dynamic scanning force microscopy investigation of nanostructured spiral-like domains in Langmuir-Blodgett monolayers. Nanotechnology 14, 245-249.
36. García, J., Martinez, L., Briceño-Valero, J. M., and Schilling C. H. (1997) Dimensional Metrology of Nanometric Spherical Particles using AFM: I. Model Development. Probe Microsc. 1, 107-116.
37. Vesenka, J., Tang, C. L., Guthold, M., Keller, D., Delaine, E., and Bustamante, C. (1992) A substrate preparation for imaging biomolecules with the scanning force microscope. Ultramicroscopy 42-44, 1243-1249.
38. Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal. Biochem. 177, 244-249.
39. LeVine, H.III (1999) Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274-284.
40. Burgio, M. R., Bennett, P. M., and Koretz, J. F. (2001) Heat induced quaternary transitions in hetero- and homo-polymers of α-crystallin. Mol. Vision 7, 228-233.
41. Blackley, H. K., Sanders, G. H., Davies, M. C., Roberts, C. J., Tendler, S. J., and Wilkinson, M. J. (2000) In-situ atomic force microscopy study of β-amyloid fibrillization. J. Mol. Biol. 298, 833-840.
42. Lee, J. C., and Timasheff, S. N. (1974) Partial specific volumes and interactions with solvent components of proteins in guanidine hydrochloride. Biochemistry 13, 251-265.
43. Makhatadze, G. I., and Privalov, P. L. (1992) Protein interactions with urea and guanidinium chloride. A calorimetric study. J. Mol. Biol. 226, 491-505.
44. Horwitz, J. (1976) Some properties of the low molecular weight α-crystallin from normal human lens: Comparison with bovine lens. Exp. Eye Res. 23, 471-481.
45. Horwitz, J., Strickland, E. H., and Billups, C. (1969) Analysis of the vibrational structure in the near-ultraviolet circular dichroism and absorption spectra of phenylalanine and its derivatives. J. Am. Chem. Soc. 91, 184-190.
46. Horwitz, J., Strickland, E. H., and Billups, C. (1970) Analysis of the vibrational structure in the near-ultraviolet circular dichroism and absorption spectra of tyrosine derivatives and ribonuclease A at 77K. J. Am. Chem. Soc. 92, 2119-2129.
47. Derham, B. K., and Harding, J. J. (1999) α-Crystallin as a molecular chaperone. Prog. Retinal Eye Res. 18, 463-509.
48. Sun, Y., and MacRae, T. H. (2005) The small heat shock proteins and their role in human disease. FEBS J. 272, 2613-2627.
49. Heath, E., and Carver, J. A. (2008) The effect of small molecules in modulating the chaperone activity of αB-crystallin against ordered and disordered protein aggregation. FEBS J. 275, 935-947.
50. Fändrich, M., Forge, V., Buder, K., Kittler, M., Dobson, C. M., and Diekmann, S. (2005) Myoglobin forms amyloid fibrils by association of unfolded polipeptide segments. Proc. Natl. Acad. Sci. U.S.A. 100, 15463-15468.
51. Babizhayev, M. A., Deyev, A. I., Yermakova, V. N., Semiletov, Y. A., Davydova, N. G., Doroshenko, V. S., Zhukotskii, A. V., and Goldman, I. M. (2002) Efficacy of N-acetylcarnosine in treatments of cataracts. Drugs R&D 3, 87-103.
52. Nicoletti, V. G., Santoro, A. M., Grasso, G., Vagliasindi L. I., Giuffrida, M. L., Cuppari, C., Purrello, V. S., Giuffrida-Stella, A. M., and Rizzarelli, E. (2007) Carnosine interaction with nitric oxide and astroglial cell protection. J. Neurosci. Res. 85, 2239-2245.
53. Calabrese, V., Colombrita, C., Guagliano, E., Sapienza, M., Ravagna, A., Cardile, V., Scapagnini, G., Santoro, A. M., Mangiameli, A., Butterfield, D. A., Giuffrida Stella, A. M., and Rizzarelli, E. (2005) Protective Effect of Carnosine During Nitrosative Stress in Astroglial Cell Cultures. Neurochem. Res. 30, 797-807.
54. Inomata, M., Hayashi, M., Shumiya, S., Kawashima, S., and Ito, Y. (2001) Involvement of inducible nitric oxide synthase in cataract formation in Shumiya cataract rat (SCR). Curr. Eye Res. 23, 307-311.
55. Nagai, N., Liu, Y., Fukuhata, T., and Ito, Y. (2006) Inhibitors of Inducible Nitric Oxide Synthase Prevent Damage to Human Lens Epithelial Cells Induced by Interferon-γ and Lipopolysaccharide. Biol. Pharm. Bull. 29, 2077-2081.
56. Babizhayev, M. A., Yermakova, V. N., Sakina, N. L., Evstigneeva, R. P., Rozhkova, E.A., and Zheltukhina, G. A. (1996) Nα-Acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant. Clin. Chim. Acta 254, 1-21.
57. Jay, J., Miller, D. J., Morrison, J. D., and O'Dowd, J. J. (1990) Histidyl derivates in rabbit lens and their diminution in human cataract. Meeting Abstracts of the Journal of Physiology of London , Proceedings Supplement, Vol. 420, p 155.
58. Stuerenburg, H. J. (2000) The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases. Biochemistry (Moscow, Russ. Fed.) 65, 862-865.